V
Volkmar Falk
Researcher at Charité
Publications - 916
Citations - 97746
Volkmar Falk is an academic researcher from Charité. The author has contributed to research in topics: Medicine & Aortic valve. The author has an hindex of 93, co-authored 801 publications receiving 85653 citations. Previous affiliations of Volkmar Falk include University of Göttingen & Intuitive Surgical.
Papers
More filters
Journal ArticleDOI
Acute type A dissection at 17 weeks of gestation in a Marfan patient.
TL;DR: A 29-year-old Marfan patient at 17 weeks of gestation was diagnosed with acute type A aortic dissection and severe aorta regurgitation and underwent a cesarean section and delivered a healthy baby.
Journal ArticleDOI
Surgical atrial septal defect closure after interventional occluder placement: incidence and outcome.
Thomas Walther,Christian Binner,Ardawan Rastan,Ingo Dähnert,Nicolas Doll,Volkmar Falk,Friedrich W. Mohr,Martin Kostelka +7 more
TL;DR: The functional outcome after secondary surgical ostium secundum atrial septal defect closure with removal of an occluder system is excellent; this must be evaluated against the extremely low risk of a standard surgical closure.
Journal ArticleDOI
Conversion of complex neonatal Ebstein’s anomaly into functional tricuspid or pulmonary atresia
TL;DR: In neonates with Ebstein's anomaly and ductal dependent pulmonary blood flow, rational palliation consists of the surgical creation of tricuspid atresia or, in the additional presence of PR or pulmonary stenosis, the creation of pulmonary atresIA.
Journal ArticleDOI
Frequency and pattern of de-novo three-vessel and left main coronary artery disease; insights from single center enrolment in the SYNTAX study
Ardawan Rastan,Enno Boudriot,Volkmar Falk,Arie Pieter Kappetein,Michael A. Borger,Patrick W. Serruys,Gerhard Schuler,Friedrich W. Mohr +7 more
TL;DR: Chronic vessel occlusion and high SYNTAX scores were more common in CABG registry patients compared to randomized patients, and patients with de-novo 3-VD/LM represented a small proportion of patients undergoing coronary angiography at the authors' center.
Journal ArticleDOI
Prediction of survival of patients in cardiogenic shock treated by surgically implanted Impella 5+ short-term left ventricular assist device.
Gaik Nersesian,Carsten Tschöpe,Frank Spillmann,T. Gromann,Luise Roehrich,Luise Roehrich,Marcus Mueller,Johanna Mulzer,Christoph Starck,Volkmar Falk,Felix Schoenrath,Evgenij Potapov +11 more
TL;DR: Impella treatment is feasible in severe CS and an algorithm for optimal short-term mechanical circulatory support selection is proposed to help identify patients who would benefit from Impella 5+ support.